ALPHA COGNITION is a commercial stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases. Alpha Cognition Inc. brings excitement and passion to our work with the goal of positively impact the lives of people living with Alzheimers and ALS. The company headquarter is located in Canada.

TickerACOG
Long NameAlpha Cognition Inc. Common Stock
Short NameAlpha Cognition